| VEGF inhibition and renal thrombotic microangiopathy V Eremina, JA Jefferson, J Kowalewska, H Hochster, M Haas, J Weisstuch, ... New England Journal of Medicine 358 (11), 1129-1136, 2008 | 1756 | 2008 |
| The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy L BARISONI, W KRIZ, P MUNDEL, V D'AGATI Journal of the American Society of Nephrology 10 (1), 51-61, 1999 | 706 | 1999 |
| Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker W Ju, V Nair, S Smith, L Zhu, K Shedden, PXK Song, LH Mariani, ... Science translational medicine 7 (316), 316ra193-316ra193, 2015 | 419 | 2015 |
| COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement F Diomedi-Camassei, S Di Giandomenico, FM Santorelli, G Caridi, ... Journal of the American Society of Nephrology 18 (10), 2773-2780, 2007 | 380 | 2007 |
| CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney TJ Soos, TN Sims, L Barisoni, K Lin, DR Littman, ML Dustin, PJ Nelson Kidney international 70 (3), 591-596, 2006 | 354 | 2006 |
| A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases L Barisoni, HW Schnaper, JB Kopp Clinical Journal of the American Society of Nephrology 2 (3), 529-542, 2007 | 340 | 2007 |
| Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study A Valeri, L Barisoni, GB Appel, R Seigle, V D'Agati Kidney international 50 (5), 1734-1746, 1996 | 323 | 1996 |
| Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach CA Gadegbeku, DS Gipson, LB Holzman, AO Ojo, PXK Song, L Barisoni, ... Kidney international 83 (4), 749-756, 2013 | 320 | 2013 |
| Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease LD Cornell, SL Chicano, V Deshpande, AB Collins, MK Selig, ... The American journal of surgical pathology 31 (10), 1586-1597, 2007 | 247 | 2007 |
| Digital pathology and computational image analysis in nephropathology L Barisoni, KJ Lafata, SM Hewitt, A Madabhushi, UGJ Balis Nature Reviews Nephrology 16 (11), 669-685, 2020 | 240 | 2020 |
| Diabetic nephropathy: is it time yet for routine kidney biopsy? MLG Suarez, DB Thomas, L Barisoni, A Fornoni World journal of diabetes 4 (6), 245, 2013 | 239 | 2013 |
| Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome JM Salvador, MC Hollander, AT Nguyen, JB Kopp, L Barisoni, JK Moore, ... Immunity 16 (4), 499-508, 2002 | 232 | 2002 |
| Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies L Barisoni, M Mokrzycki, L Sablay, M Nagata, H Yamase, P Mundel Kidney international 58 (1), 137-143, 2000 | 232 | 2000 |
| Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival H Kato, A Gruenwald, JH Suh, JH Miner, L Barisoni-Thomas, MM Taketo, ... Journal of Biological Chemistry 286 (29), 26003-26015, 2011 | 223 | 2011 |
| HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy L Barisoni, LA Bruggeman, P Mundel, VD D'agati, PE Klotman Kidney international 58 (1), 173-181, 2000 | 212 | 2000 |
| Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations PL Kimmel, L Barisoni, JB Kopp Annals of internal medicine 139 (3), 214-226, 2003 | 206 | 2003 |
| Podocyte biology and the emerging understanding of podocyte diseases L Barisoni, P Mundel American journal of nephrology 23 (5), 353-360, 2003 | 197 | 2003 |
| Collapsing glomerulopathy M Albaqumi, TJ Soos, L Barisoni, PJ Nelson Journal of the American Society of Nephrology 17 (10), 2854-2863, 2006 | 189 | 2006 |
| An eQTL landscape of kidney tissue in human nephrotic syndrome CE Gillies, R Putler, R Menon, E Otto, K Yasutake, V Nair, P Hoover, ... The American Journal of Human Genetics 103 (2), 232-244, 2018 | 181 | 2018 |
| Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 … DP Germain, R Giugliani, DA Hughes, A Mehta, K Nicholls, L Barisoni, ... Orphanet journal of rare diseases 7, 1-11, 2012 | 172 | 2012 |
